Study Shows Simeprevir Improves Hep C Therapy
Addition of simeprevir to peginterferon/ribavirin improves SVR rate among HCV patients
May 1, 2013
Simeprevir improves rates of sustained virologic response and may allow for a 24-week treatment duration when added to interferon-based therapy for chronic hepatitis C, according to data presented at the International Liver Congress in Amsterdam.
Continue reading this entire article: